Navigation Links
Dehaier Medical Systems Announces Engagement of RedChip Companies to Lead Public and Investor Relations
Date:9/9/2010

Dehaier Medical Systems Announces Engagement of RedChip Companies to Lead Public and Investor Relations -- BEIJING, Sept. 9 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Equipment, Contracts Click to view news release full screen  

Dehaier Medical Systems Announces Engagement of RedChip Companies to Lead Public and Investor Relations

 

BEIJING, Sept. 9 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems, Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing, and sale of medical devices and homecare medical products in China, announced today that it has retained RedChip Companies, Inc. to lead its public and investor relations programs.

(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100422/CNTH001LOGO)

"We have heard nothing but positive reports about RedChip's track record of increasing investor awareness and visibility for emerging growth companies in the small cap space," said Mr. Ping Chen, CEO of Dehaier Medical Systems. "We are excited to have the RedChip team heading our investor relations program and providing guidance and input. We are certain that RedChip's strong investor network and public relations platform will increase our visibility and help us reach a broader investor audience."

"We are pleased to have the opportunity to represent Dehaier Medical," said Dave Gentry, President and CEO of RedChip Companies, Inc. "As China's population continues to age, the number of people over the age of 60 is expected to grow at a rate of 6 million per year, creating an enormous long-term potential market for companies like Dehaier. The Company's ongoing relationships with thousands of distributors and hospitals across China put it in a strong position competitively to become one of the dominant medical device distributors in the country. We look forward to implementing our comprehensive investor and public relations program and introducing Dehaier Medical to our extensive network of investors."

About Dehaier Medical Systems Ltd.

Dehaier Medical Systems is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The Company develops and assembles its own branded products from third-party components. The Company also distributes products designed and manufactured by other companies, including medical devices and respiratory and oxygen homecare products from IMD (Italy), Welch Allyn (USA), Penlon (UK), HEYER (Germany), Timesco (UK), ResMed (Australia) and JMS (Japan). Dehaier's technology is based on two patents, five pending patents, and proprietary technology. More information may be found at http://www.chinadhr.com .

About RedChip Companies, Inc.

RedChip Companies is an international, small-cap research and financial public relations firm headquartered in Orlando, Florida; with affiliate offices in Beijing, China; Paris, France; and Seoul, Korea. RedChip delivers concrete, measurable results for its clients through its extensive national and international network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research(TM), Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, RedChip Small-Cap TV(TM), Shareholder Intelligence, Social Media and Blogging Services, Webcasts, and RedChip Radio(TM). To learn more about RedChip's products and services please visit: http://www.redchip.com/visibility/productsandservices.asp .

Forward-looking statements

The above news release contains forward-looking statements. The statements contained in this document that are not statements of historical fact, including but not limited to, statements identified by the use of terms such as "anticipate," "appear," "believe," "could," "estimate," "expect," "hope," "indicate," "intend," "likely," "may," "might," "plan," "potential," "project," "seek," "should," "will," "would," and other variations or negative expressions of these terms, including statements related to expected market trends and the Company's performance, are all "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve a number of risks and uncertainties. These statements are based on assumptions that management believes are reasonable based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performances, and are subject to a wide range of external factors, uncertainties, business risks, and other risks identified in filings made by the company with the Securities and Exchange Commission. Actual results may differ materially from those indicated by such forward-looking statements. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.

For more information, please contact: At the company: Gui Shuguang Dehaier Medical Systems Ltd. Phone: +86-10-5166-0080 x169 Email: guishg@dehaier.com.cn Investor relations: Dave Gentry RedChip Companies, Inc. Phone: 1-800-733-2447 x104 Email: info@redchip.com Web: http://www.RedChip.com
'/>"/>

SOURCE Dehaier Medical Systems Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27
2. Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line
3. Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco
4. Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell
5. Dehaier Medical Systems Announces New Exclusive China Distribution Agreement with Welch Allyn, Further Broadening Companys Product Lines
6. Dehaier Medical Systems Announces First Quarter Net Income Up 54%
7. Dehaier Medical Systems Announces Closing of Initial Public Offering on NASDAQ
8. Spirus Medical Announces Japanese Regulatory Approval to Market ENDO-EASE® Product Line
9. Winner Medical Group Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13 at 3:40 pm ET
10. UBM TechInsights Expands Presence in the Medical Devices Sector
11. Symmetry Medical to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 2017 Research and Markets has announced the ... - 2016" report to their offering. ... The latest research Urinary Incontinence Drugs ... benchmarks in the global Urinary Incontinence market. The research answers ... key drugs marketed for Urinary Incontinence and their clinical attributes? How ...
(Date:2/23/2017)... Feb. 23, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... innovative proprietary products for the urology market, will release ... ended December 31, 2016 before the market open on ... will host a conference call and webcast to discuss ... 9, 2017 at 11:00 a.m. Eastern Time (10:00 a.m. ...
(Date:2/23/2017)... 2017 Research and Markets has announced the ... - 2016" report to their offering. ... The latest research Oesophageal Cancer Drugs ... benchmarks in the global Oesophageal Cancer market. The research ... the key drugs marketed for Oesophageal Cancer and their clinical attributes? ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... 2017 , ... Functional imaging data supports improved cognition in ... today at the 1st Pan American Parkinson’s and Movement Disorders Congress. , It ... improving cognitive function in PD patients. This study, led by Ibarretxe-Bilbao et al., ...
(Date:2/24/2017)... ... February 24, 2017 , ... Houston dentist ... his office, Antoine Dental Center. Currently, patients can get single dental implants for ... but patients can learn more about these offers by contacting Antoine Dental Center. ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... provost of Liberty University, has officially announced the appointment of Peter A. Bell, ... College of Osteopathic Medicine (LUCOM), beginning April 10. Dr. Bell comes to ...
(Date:2/24/2017)... ... 24, 2017 , ... Healthcare Associates of McKinney announced today that ... at 8080 State Highway 121, Suite 210, McKinney, Texas 75070. It is in ... , As the practice has grown, the need for more space has been paramount. ...
(Date:2/24/2017)... ... February 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... concerning this present generation. Yisrayl makes an astounding statement when he says that ... explains that the Bible details the current times so plainly that anyone should be ...
Breaking Medicine News(10 mins):